CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia

PartnershipOpzeluraPositive
AI Analysis

Summary

Specialised Therapeutics expanded its existing partnership with Incyte to commercialise, distribute, and register Opzelura (ruxolitinib cream) in Australia.

Importance:6/10
Sentiment:
0.60
partnershipexpansioncommercializationAustraliaruxolitinib
Related Companies

Read the original article

Published by PR Newswire Biotech on September 20, 2026 8:00 PM

Read Original